NUVB - Nuvation Bio Inc.
NEXT EARNINGS:
Mar 2, 2026
(in 5 days)
EPS Est: $-0.11
|
Rev Est: $37.5M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.40
DETAILS
HIGH:
$17.00
LOW:
$10.00
MEDIAN:
$12.00
CONSENSUS:
$12.40
UPSIDE:
119.86%
Market Cap:
1.93B
Volume:
4,516,234
Avg Volume:
5,886,988
52 Week Range:
1.54-9.75
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.53
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
273
IPO Date:
2020-08-26
EPS (TTM):
-2.11
P/E Ratio:
-1.26
Revenue (TTM):
7.87M
Total Assets:
540.63M
Total Debt:
8.91M
Cash & Equiv:
35.72M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-117.7%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-03 | $-0.16 | $-0.17 | +5.9% | $13.1M | $36.8M | -64.4% |
| 2025-08-07 | $-0.17 | $-0.17 | 0.0% | $4.8M | $3.6M | +33.4% |
| 2025-05-07 | $-0.16 | $-0.16 | 0.0% | $3.1M | $357140 | +763.5% |
| 2025-03-06 | $-0.15 | $-0.14 | -7.1% | $5.7M | $833330 | +585.3% |
| 2024-11-06 | $-0.15 | $-0.13 | -15.4% | $727000 | — | — |
| 2024-08-05 | $-0.15 | $-0.06 | -150.0% | $1.4M | — | — |
| 2024-05-14 | $-0.07 | $-0.08 | +12.5% | — | — | — |
| 2024-02-29 | $-0.06 | $-0.10 | +40.0% | $264000 | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 7.87M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (567.94M) | (75.80M) | (104.20M) | (86.85M) | (41.66M) | (33.55M) | (992,000) |
| EPS | -2.11 | -0.35 | -0.48 | -0.44 | -0.19 | -0.16 | -0.01 |
| Total Assets | 540.63M | 621.48M | 672.14M | 776.15M | 221.79M | 120.95M | 158,000 |
| Total Debt | 8.91M | 4.01M | 4.26M | 3.06M | 0 | 0 | 600,000 |
| Cash & Equivalents | 35.72M | 42.65M | 101.10M | 132.42M | 29.75M | 3.47M | 138,000 |
| Operating Cash Flow | (130.41M) | (68.00M) | (96.11M) | (68.19M) | (36.53M) | (24.43M) | (616,000) |
| Free Cash Flow | (130.57M) | (68.07M) | (96.48M) | (68.47M) | (36.67M) | (25.09M) | (616,000) |
| FCF per Share | -0.49 | -0.31 | -0.45 | -0.35 | -0.17 | -0.12 | -0.00 |
| Book Value | 463.79M | 605.12M | 655.08M | 746.00M | 215.08M | 117.75M | (744,000) |
| Cash & ST Investments | 502.69M | 611.21M | 661.01M | 765.39M | 215.75M | 118.87M | 138,000 |
| ROC Equity | -1.22 | -0.13 | -0.16 | -0.12 | -0.19 | -0.28 | N/A |